Lee Ainslie Petmed Express Inc Transaction History

Maverick Capital LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.21 - $14.65 $280,407 - $402,347	27,464 New	27,464 $281,000
Q4 2022 Feb 14, 2023	BUY	$17.16 - $22.14 $310,578 - $400,711	18,099 Added 31.72%	75,161 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$19.35 - $23.52 $1.1 Million - $1.34 Million	57,062 New	57,062 $1.11 Million
Q1 2021 May 17, 2021	SELL	$29.77 - $51.8 $2.27 Million - $3.95 Million	-76,310 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.96 - $33.77 $2.21 Million - $2.58 Million	76,310 New	76,310 $2.45 Million
Q2 2020 Aug 14, 2020	SELL	$27.94 - $40.96 $5.79 Million - $8.49 Million	-207,225 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$22.18 - $28.78 $4.6 Million - $5.96 Million	207,225 New	207,225 $5.96 Million
Q3 2018 Nov 14, 2018	SELL	$33.01 - $44.57 $182,380 - $246,249	-5,525 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$33.46 - $46.17 $184,866 - $255,089	5,525 New	5,525 $243,000
Q1 2018 May 15, 2018	SELL	$41.2 - $53.24 $3.94 Million - $5.09 Million	-95,653 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$34.19 - $48.11 $3.27 Million - $4.6 Million	95,653	95,653 $4.35 Million

102

9.52M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $102M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.